January 9, 2015

Precise Renal Function Testing Helps Post-Nephrectomy Management

Including proteinuria improves adverse outcome forecasting

Demirijian-Hero-Image-690x380pxl

By Sevag Demirjian, MD

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Large-scale epidemiologic studies have shown that chronic kidney disease is an important risk factor for adverse clinical outcomes. The latter includes not only progression to end-stage renal disease but a significant increase in cardiovascular events and all-cause mortality.

Chronic kidney disease initiation and progression have traditionally been confined to those with chronic medical conditions such as diabetes mellitus and hypertension. However, there is a significant and rising incidence of kidney disease that develops among those who sustain loss in functioning nephron mass due to acute kidney injury. This is self-evident in an aging population with multiple comorbidities who undergo major cardiovascular surgeries, and among those who undergo nephrectomy of renal cell cancer, often driven by the increasing number of detected incidental renal masses.

Patients presenting with renal cancer are not analogous to kidney transplant donors who are proven to have a clean bill of health after going through extensive evaluation that ensures their long-term outcome. Subsequently, it isn’t surprising that accurate measurement of renal function plays a critical role in counseling and informing patients and physicians alike regarding long-term renal outcomes following nephrectomy procedures.

Evaluating Renal Function

The gold standard for accurate assessment of renal function is the direct measurement of compounds that are filtered and not secreted or absorbed in the kidneys, such as inulin or iothalamate. However, these tests are available only in select academic medical centers and require significant cost, time and expertise to perform.

Advertisement

We evaluated the performance of existing estimation equations such as Cockcroft-Gault, Modification of Diet in Renal Disease, and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) versus measured glomerular filtration rate using iothalamate. CKD-EPI marginally outperformed the other equations and fared significantly better than serum creatinine alone in patients with renal cancer undergoing nephrectomy; however, it lacked precision when compared with direct measurement with iothalamate.

The widespread use of creatinine-based estimation equations of renal function has increased awareness among physicians and the public about kidney disease prevalence and its clinical implications. The relationship between chronic kidney disease and adverse clinical outcomes is robust, but outcome prediction can be improved by incorporating proteinuria, which has proven its prognostic value in numerous well-performed studies.

We have all seen patients who, although they have a similar baseline renal function, progress to advanced renal disease at different rates. For example, in a cohort of 920,985 adults receiving community-based care in Canada, the risks of mortality, myocardial infarction and progression to kidney failure associated with a given level of eGFR independently increased in patients with higher levels of proteinuria.

At Cleveland Clinic, we have established a longitudinal multidisciplinary clinic for patients with kidney cancer. We use combined surgical and medical approaches in striving to cure cancer while preserving long-term renal function and overall survival by optimizing perioperative and follow-up care.

Advertisement

Demirijian-Inset-Chart-590pxl-width

Dr. Demirjian is a staff member of the Department of Nephrology and Hypertension in Cleveland Clinic’s Glickman Urological & Kidney Institute.

Related Articles

Man sitting at kitchen table with blood pressure monitor and pill bottles
March 19, 2024
Should Patients Take Blood Pressure Medications in the Evening to Enhance Cardiovascular Benefit?

Clinicians should individualize dosing practices based on patient risk factors and preferences

Drawing of a pink bulb with two tubes coming out of the top
March 13, 2024
Predicting Post-Op GFR: AI Algorithm Is as Accurate as Clinical Model

Fully-automated process uses preop CT, baseline GFR to estimate post-nephrectomy renal function

Arm of Black patient having kidney dialysis
March 8, 2024
GFR Equations: How Will Eliminating the Race Coefficient Affect Black Patients?

Could mean earlier treatment, but also could have negative effects

Senior at the Doctors
December 29, 2023
Study Assesses the Utility of Renal Genetic Testing in Black Patients

Identifying barriers in the renal genetic assessment of Black patients

GUKI Care Page of Dr. George Thomas and Angela Smith
June 1, 2023
Resistant Hypertension: A Stepwise Approach

Getting patients to their goal blood pressure

urine bottle held by healthcare professionals with latex glove, toxicology test
April 10, 2023
Nephrologist-Led Urine Microscopy Edges Out Automated Technology in Predicting AKI

Study highlights benefits of nephrologist-led urine sediment analysis

23-URL-3773974-CQD-650×450-1
April 3, 2023
New Data Suggest Kidney Diseases With No Known Cause May Be Linked to Viruses

Using sequencing data to identify novel factors linked to kidney disease with unknown origin

650×450-Wang
February 22, 2023
A 3-Year Review of Real-World Experience in the Renal Genetics Clinic

Program plays key role in diagnosis and management of genetic kidney diseases

Ad